EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Lipid-Based Delivery Systems for Therapeutic Glycoproteins: Current Advances, Challenges, and Future Perspectives

Hamad Alrbyawi iD

Pharmaceutics · 22.08.2026 · 18 (9) · 1045

DOI: 10.3390/pharmaceutics18091045 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 22.08.2026. Verfasst von Hamad Alrbyawi. Beteiligte Einrichtung: Department of Pharmaceutics and Pharmaceutical Industries, College of Pharmacy, Taibah University, Al-Madinah Al-Munawarah 41477, Saudi Arabia. Die Arbeit nennt 145 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Therapeutic glycoproteins, a pivotal class of biopharmaceuticals, have transformed modern medicine through their broad applications in oncology, immunotherapy, and infectious disease management. Their structural complexity and biological specificity make them highly effective in targeting disease pathways; however, challenges related to stability, bioavailability, and delivery efficacy limit their full potential. Recent advancements in delivery technologies have sought to address these challenges through innovative approaches such as nanotechnology-based carriers, controlled-release systems, and molecular engineering. These strategies have demonstrated the ability to enhance glycoprotein stability, optimize pharmacokinetics, and achieve targeted delivery with minimal off-target effects. This review provides a comprehensive overview of state-of-the-art lipid-based delivery systems specifically designed to overcome the unique pharmaceutical challenges associated with therapeutic glycoproteins, highlighting their design principles, formulation strategies, mechanisms of encapsulation and release, and therapeutic advantages in improving glycoprotein stability, bioavailability, targeted delivery, and treatment efficacy. In addition to surveying the current landscape, this review delves into the key challenges impeding the widespread adoption of advanced delivery systems, including immunogenicity, manufacturing scalability, and clinical translation. The review concludes with insights into emerging trends in the development of lipid-based delivery systems, positioning glycoprotein therapeutics at the forefront of innovation in biopharmaceuticals. This overview of advancements and challenges aims to provide a roadmap for future progress in the field of glycoprotein delivery and therapeutic applications.

Schlagwörter

Stichwörter der Autor:innen

glycoprotein deliverylipid-based nanocarriersliposomessolid lipid nanoparticlestargeted drug deliverytherapeutic glycoproteins

Autor:innen und Institutionen

  • Department of Pharmaceutics and Pharmaceutical Industries, College of Pharmacy, Taibah University, Al-Madinah Al-Munawarah 41477, Saudi Arabia.

ORCID-Profile: Hamad Alrbyawi

Zitieren

APA

Alrbyawi, H. (2026). Lipid-Based Delivery Systems for Therapeutic Glycoproteins: Current Advances, Challenges, and Future Perspectives. Pharmaceutics, 18(9), 1045. https://doi.org/10.3390/pharmaceutics18091045

Vancouver

Alrbyawi H. Lipid-Based Delivery Systems for Therapeutic Glycoproteins: Current Advances, Challenges, and Future Perspectives. Pharmaceutics. 2026;18(9):1045. doi:10.3390/pharmaceutics18091045

BibTeX
@article{Alrbyawi2026,
  author = {Alrbyawi, Hamad},
  title = {Lipid-Based Delivery Systems for Therapeutic Glycoproteins: Current Advances, Challenges, and Future Perspectives},
  journal = {Pharmaceutics},
  year = {2026},
  volume = {18},
  number = {9},
  pages = {1045},
  doi = {10.3390/pharmaceutics18091045}
}
Kostenlos starten →